ResMed Financial Ratios

ResMed Inc -- USA Stock  

USD 87.8  0.88  0.99%

Use fundamental data analysis to confirm all available drivers of ResMed Inc to find out if markets are presently mispricing the firm. We found thirty-six available financial ratios for ResMed Inc which can be compared to its competitors. To make sure the equity is not overpriced, please check all ResMed Inc fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed Inc has Price to Earning of 36.09 times, we recommend you check out ResMed Inc recent market performance to make sure the company can sustain itself down the road.Use ResMed to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of ResMed to be traded at $86.04 in 30 days

ResMed Inc Valuation Over Time

Enterprise Value

ResMed Company Summary

ResMed competes with DexCom, Boston Scientific, Cooper Companies, Quest Diagnostics, and DENTSPLY INTL. Its portfolio of solutions include devices such as air flow generators ventilators and oxygen concentrators diagnostic products mask systems headgear and other accessories dental devices portable oxygen concentrators and cloudbased software informatics solutions. ResMed Inc also produces continuous positive airway pressure variable positive airway pressure and AutoSet systems for the titration and treatment of sleep disordered breathing . In addition it offers data communications and control products such as EasyCare ResLink ResControl ResControl II TxControl ResScan and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc markets its solutions to sleep clinics home healthcare dealers patients hospitals physicians and thirdparty payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego California.

ResMed Current Valuation vs Book Value Per Share

ResMed Inc is rated fifth in current valuation category among related companies. It is rated fifth in book value per share category among related companies . The ratio of Current Valuation to Book Value Per Share for ResMed Inc is about  888,272,033 

ResMed Inc Systematic Risk

The output start index for this execution was five with a total number of output elements of twelve. The Beta measures systematic risk based on how returns on ResMed Inc correlated with the market. If Beta is less then 0 ResMed generally moves in the opposite direction as compared to the market. If ResMed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ResMed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ResMed is generally in the same direction as the market. If Beta > 1 ResMed moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 6% 

Chance of Financial Distress

ResMed Inc has less than 6 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


ResMed Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare ResMed To Peers
Michael Farrell CEO and Director, MBA
Peter Farrell Non-Executive Chairman of the Board, Ph.D
More Executives

Opportunity Range

January 22, 2018 Opportunity Range